Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT04795063

Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer

Randomized Controlled Trials on Clinical Outcomes of Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Fujian Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To evaluate the clinical efficacy (safety, feasibility and long-term efficacy) of total robotic versus robotic assisted distal gastrectomy for patients with gastric cancer (cT1-4a, N0/+, M0).

Detailed description

In the field of gastrectomy, Hashizume et al. first reported robotic gastrectomy in 2002. Since then, reports on the safety and feasibility of the application of robotic surgical system in the treatment of gastric cancer (GC) have gradually increased. Reports of robotic surgery for GC are increasing, especially in Asia. Several studies confirmed the advantages of robotic gastrectomy when compared with laparoscopic gastrectomy. However, whether total robotic gastrectomy is noninferior to robotic-assisted gastrectomy remains unclear. The investigator first carried out this study in the world to evaluate the efficacy of total robotic versus robotic assisted distal gastrectomy for GC.

Conditions

Interventions

TypeNameDescription
PROCEDURETotal Robotic Distal GastrectomyAll the surgical procedures are performed using the robot system.
PROCEDURERobotic-Assisted Distal GastrectomyAfter finishing the lymphadenectomy, the digestive tract reconstruction is performed extracorporal.

Timeline

Start date
2021-03-01
Primary completion
2024-01-01
Completion
2027-01-01
First posted
2021-03-12
Last updated
2021-03-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04795063. Inclusion in this directory is not an endorsement.